Last updated August 29, 2026
Key finding
Families in the intervention group were more likely than those in the control group to review their glucose data using mobile health apps after 1 month (P <.001).
This pilot study evaluated the feasibility of remote glucose monitoring in pediatric patients with newly diagnosed Type 1 diabetes. It found that families using remote monitoring were more likely to review glucose data after one month compared to usual care.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot study evaluated the feasibility of remote glucose monitoring in pediatric patients with newly diagnosed Type 1 diabetes. It found that families using remote monitoring were more likely to review glucose data after one month compared to usual care.
This study provides insights into the potential of remote glucose monitoring to enhance patient engagement in managing Type 1 diabetes. While initial benefits were observed, the lack of sustained differences raises questions about the long-term effectiveness of such interventions. Understanding these dynamics can help inform future strategies for diabetes management in pediatric populations.
Limited sample size may affect generalizability. Short follow-up period may not capture long-term effects. No assessment of clinical outcomes like glycemic control.
Published in
Publication details and source links for this paper.
Dina G, Kara M, Daniel D, et al. Feasibility of Remote Glucose Monitoring in Pediatric Patients with Newly Diagnosed Type 1 Diabetes: A Pilot Study. JMIR Diabetes. 2022;7(1):e33639. doi:10.2196/33639
Families in the intervention group were more likely to review glucose data after 1 month (P <.001).
By 6 months, the difference in data review between groups disappeared.
Perceived ease of contacting the clinical team was similar for both groups after 6 months (P =.48).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Continuous glucose monitoring, Usual care and Improvement in glucose handling following GLP-1RA treatment, Perceived ease of contacting clinical team for assistance after 6 months, Self-review of glucose data after 6 months, and 1 more.
This study contributes evidence to
Primary intervention
Continuous glucose monitoring
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
5
Evidence pairs
207
Related studies
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
matched_intervention
Core evidence
The primary outcomes reported in this study.
Continuous glucose monitoring → Improvement in glucose handling following GLP-1RA treatment
Continuous glucose monitoring → Improvement in glucose handling following GLP-1RA treatment
Continuous glucose monitoring → Perceived ease of contacting clinical team for assistance after 6 months
Continuous glucose monitoring → Perceived ease of contacting clinical team for assistance after 6 months
Continuous glucose monitoring → Self-review of glucose data after 6 months
Continuous glucose monitoring → Self-review of glucose data after 6 months
Usual care → Improvement in glucose handling following GLP-1RA treatment
Usual care → Improvement in glucose handling following GLP-1RA treatment
Usual care → Usefulness of Motivational Interviewing and Health Action Process Approach in Training
Usual care → Usefulness of Motivational Interviewing and Health Action Process Approach in Training
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Delivery Systems and Perceived ease of contacting clinical team for assistance after 6 months, Insulin Delivery Systems and Improvement in glucose handling following GLP-1RA treatment.
This study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Devices & Technology
Curated evidence collections and hubs this study is part of.
All studies measuring Improvement in glucose handling following GLP-1RA treatment
Measures Improvement in glucose handling following GLP-1RA treatment as a key outcome.
All studies on Insulin Delivery Systems
Contributes to Insulin Delivery Systems evidence base.
All studies measuring Perceived ease of contacting clinical team for assistance after 6 months
Measures Perceived ease of contacting clinical team for assistance after 6 months as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Usual care appears to improve Usefulness of Motivational Interviewing and Health Action Process Approach in Training.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Usefulness of Motivational Interviewing and Health Action Process Approach in Training
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Continuous glucose monitoring for Perceived ease of contacting clinical team for assistance after 6 months.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Perceived ease of contacting clinical team for assistance after 6 months
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Continuous glucose monitoring for Self-review of glucose data after 6 months.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Self-review of glucose data after 6 months
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Continuous glucose monitoring may worsen Improvement in glucose handling following GLP-1RA treatment or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Improvement in glucose handling following GLP-1RA treatment
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
